Identification of 5mC regulatory factors mediating methylation patterns and prognosis models in head and neck squamous cell carcinoma
Rattachement africain : cn. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
BACKGROUND: This study explores the role of 5mC regulatory genes in head and neck squamous cell carcinoma (HNSCC), focusing on their association with tumor progression, metastasis, and prognosis. A prognostic model was also developed to predict patient survival. MATERIALS AND METHODS: Using expression profile data from the GEO and TCGA databases, the study analyzed the differential expression of 5mC-related genes, their connection with somatic mutations, and their impact on the immune microenvironment. A prognostic risk model based on these genes was constructed through the differential expression of 5mC-related genes. RESULTS: (1) Several 5mC regulatory factors were found to be abnormally expressed in HNSCC, with a significant association with somatic mutations. (2) Different 5mC methylation regulation patterns showed variations in immune infiltration, immune checkpoint expression, tumor mutation burden, and cancer stem cell gene set expression, potentially influencing immunotherapy effectiveness and prognosis. (3) Prognosis-related risk genes, such as DNMT1 and TET2, were identified as predictors of survival outcomes in HNSCC patients. CONCLUSIONS: The methylation patterns of 5mC regulatory factors are critical in HNSCC progression and are closely linked to tumor microenvironment infiltration. These findings offer new perspectives for treatment strategies and prognosis prediction in HNSCC.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Identification of 5mC regulatory factors mediating methylation patterns and prognosis models in head and neck squamous cell carcinoma
- Date Crossref
- 12/11/2025
- Éditeur
- Springer Science and Business Media LLC
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Tianjin University Academy of Medical Engineering and Translational Medicine pays non établi dans la noticeUniversité ou école supérieure
-
Tianjin Medical University Cancer Institute and Hospital Department of Integrative Oncology pays non établi dans la noticeÉtablissement de santé
-
Tianjin Medical University pays non établi dans la noticeUniversité ou école supérieure
Academy of Medical Engineering and Translational Medicine — Tianjin University, Department of Integrative Oncology — Tianjin Medical University Cancer Institute and Hospital et Tianjin Medical University.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.